Skip to content

Quality of Life Comparison in Patients With Different Types of Alopecia

Quality of Life Comparison in Patients With Different Types of Alopecia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04246957
Acronym
RDACCQV
Enrollment
100
Registered
2020-01-29
Start date
2019-03-04
Completion date
2020-11-16
Last updated
2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia, Quality of Life

Keywords

alopecia, quality of life, partner

Brief summary

Hair loss is a frequent cause of patient consultation in dermatology. It is known to have a strong impact on patients' quality of life for many reasons; such as esthetic aspect, financial implications, social consequences. Numerous studies have assessed the impact of some types of alopecia on patients' quality of life. One study compared the quality of life in patients with scarring alopecia with patients of non-scarring alopecia. No studies have compared quality of life between the different types of scarring alopecia nor different types of non-scarring alopecia. However, none have assessed the impact on the patient partner quality of life. In addition, few treatments for alopecia are covered by national health insurance in France. The main objective is to compare the impact on the quality of life in different types of alopecia. By using the average scores of the questionnaire Dermatology Life Quality Index (DLQI) for each type of alopecia.

Interventions

BEHAVIORALgeneral quality of life questionary

Every patient will have to fill out a general quality of life questionary : DLQI (Dermatology Life Quality Index)

BEHAVIORALspecific quality of life questionary

Every patient will have to fill out a specific quality of life questionary : Hair Specific Skindex 29.

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients affiliated to social security * patients able to understand and fill out a questionnaire * patients over 18 years old * patient consulting in the dermatology department of Amiens University Hospital for a primary alopecia

Exclusion criteria

* minors * patients under guardianship, deprived of liberty * scalp affections other than alopecia * secondary alopecia

Design outcomes

Primary

MeasureTime frameDescription
Variation of score of questionnaire Dermatology Life Quality Index (DLQI) according alopecia type in patient lifeat day 0The Dermatology life Quality Index (DLQI) is a ten-question questionnaire used to measure the impact of skin disease on the quality of life of an affected person. It is designed for people aged 16 years and above. There are 10 questions, covering the following topics: symptoms, embarrassment, shopping and home care, clothes, social and leisure, sport, work or study, close relationships, sex, treatment. Each question refers to the impact of the skin disease on the patient's life over the previous week. Each question is scored from 0 to 3, giving a possible score range form 0 (meaning no impact of skin disease on quality of life) to 30 (meaning maximum impact on quality of life).

Secondary

MeasureTime frameDescription
Variation of score of questionnaire Dermatology Life Quality Index (DLQI) according alopecia type in spouse lifeat day 0The Dermatology life Quality Index (DLQI) is a ten-question questionnaire used to measure the impact of skin disease on the quality of life of an affected person. It is designed for people aged 16 years and above. There are 10 questions, covering the following topics: symptoms, embarrassment, shopping and home care, clothes, social and leisure, sport, work or study, close relationships, sex, treatment. Each question refers to the impact of the skin disease on the patient's life over the previous week. Each question is scored from 0 to 3, giving a possible score range form 0 (meaning no impact of skin disease on quality of life) to 30 (meaning maximum impact on quality of life).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026